Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma?

In this review, we highlight prospective data on checkpoint inhibition alone and in combination, discuss data regarding the efficacy and toxicity of combination therapy, and identify clinical scenarios that may favor treatment with combination therapy.

Source: CancerNetwork - May 15, 2018 Category: Cancer & Oncology Authors: Allison Betof Warner, MD, PhD Michael A. Postow, MD Tags: Melanoma Oncology Journal Review Article Source Type: news